share_log
Reuters ·  May 8 16:01
Bionano Genomics Inc Sees to Have Reduced Annualized Non-Gaap Operating Expenses by About $65.0 to $75.0 Mln by Q1 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment